Education
About Us
Working with TipRanks
Follow Us
4D Molecular Therapeutics (FDMT)
NASDAQ:FDMT
4D-150 Ivt (3E10 Vg/Eye), Eylea® (Aflibercept) Injection 2 Mg (0.05Ml)
Neovascular Age-Related Macular Degeneration (Namd)
Phase III
Recruiting
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Jul 07, 2025
―
4D-150 Ivt (3E10 Vg/Eye), Eylea® (Aflibercept) Injection 2 Mg (0.05Ml)
Macular Neovascularization Secondary To Age-Related Macular Degeneration
Phase III
Recruiting
4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Mar 04, 2025
―
4D-150 Ivt, Aflibercept Ivt
Diabetic Macular Edema, Diabetic Retinopathy
Phase II
Active Not Recruiting
4D-150 in Patients With Diabetic Macular Edema
Jun 26, 2023
―
4D-310
Fabry Disease
Phase I/II
Recruiting
4D-310 in Adults With Fabry Disease and Cardiac Involvement
Nov 04, 2022
―
4D-710
Cystic Fibrosis Lung
Phase I/II
Recruiting
4D-710 in Adult Patients With Cystic Fibrosis
Feb 10, 2022
―
4D-150 Ivt, Aflibercept Ivt
Neovascular (Wet) Age-Related Macular Degeneration
Phase I/II
Recruiting
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
Jan 05, 2022
―
Observational, 4D-125 Ivt Injection
X-Linked Retinitis Pigmentosa
Phase I/II
Active Not Recruiting
4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)
Aug 14, 2020
―
4D-110
Choroideremia
Phase I
Active Not Recruiting
Dose Escalation Study of Intravitreal 4D-110 in Patients With Choroideremia
Jul 20, 2020
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does 4D Molecular Therapeutics (FDMT) have in its pipeline
FDMT is currently developing the following drugs: 4D-150 Ivt (3E10 Vg/Eye), Eylea® (Aflibercept) Injection 2 Mg (0.05Ml), 4D-150 Ivt (3E10 Vg/Eye), Eylea® (Aflibercept) Injection 2 Mg (0.05Ml), 4D-150 Ivt, Aflibercept Ivt. These drug candidates are in various stages of clinical development as the company works toward FDA approval.